Accelerate Diagnostics, Inc.

AXDX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$50-$62-$62-$78
Dep. & Amort.$3$3$3$3
Deferred Tax$0$0$0-$6
Stock-Based Comp.$4$5$11$22
Change in WC$3$5$2-$0
Other Non-Cash$15$8-$2$12
Operating Cash Flow-$24-$40-$49-$47
Investing Activities
PP&E Inv.-$1-$1-$1-$1
Net Acquisitions$0$0$1$1
Inv. Purchases$0$0-$28-$30
Inv. Sales/Matur.$0$10$40$39
Other Inv. Act.$0$0-$1-$1
Investing Cash Flow-$1$9$12$8
Financing Activities
Debt Repay.-$1$9-$1-$0
Stock Issued$30$4$33$43
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$4$0$1
Financing Cash Flow$27$9$32$43
Forex Effect$1-$0-$0-$0
Net Chg. in Cash$3-$23-$5$4
Supplemental Information
Beg. Cash$12$35$40$36
End Cash$15$12$35$40
Free Cash Flow-$25-$41-$49-$48
Accelerate Diagnostics, Inc. (AXDX) Financial Statements & Key Stats | AlphaPilot